Anti-HBc (antibody to hepatitis B core antigen) is a blood marker that shows your immune system has encountered the hepatitis B virus at some point. Unlike the antibody produced by vaccination, anti-HBc only appears after actual infection, making it one of the most reliable indicators of whether someone has ever been exposed to hepatitis B. It can signal an active infection, a past infection you’ve recovered from, or a chronic infection, depending on what other markers show up alongside it.
What Anti-HBc Actually Detects
The hepatitis B virus has a protein shell called the core antigen (HBcAg). This core sits inside infected liver cells and never circulates freely in the bloodstream, so it can’t be measured directly with a blood test. Your immune system, however, produces antibodies against it, and those antibodies do show up in blood. That’s what the anti-HBc test measures: your body’s antibody response to a part of the virus that’s otherwise invisible to standard testing.
This is what makes anti-HBc uniquely useful. People who are immune to hepatitis B through vaccination develop a different antibody (anti-HBs) because the vaccine contains only the surface protein, not the core. If anti-HBc is positive, the person was infected with the actual virus at some point. If it’s negative, the person was likely never exposed.
IgM vs. Total Anti-HBc
Anti-HBc comes in two forms that labs can measure separately, and the distinction matters because it helps pinpoint timing.
- IgM anti-HBc is the version your immune system produces first. It appears early during an acute infection and typically fades within six months. A positive IgM anti-HBc generally means you’re dealing with a new or recent infection.
- Total anti-HBc captures both IgM and a longer-lasting antibody called IgG. Once total anti-HBc becomes positive, it usually stays positive for life. This makes it a permanent footprint of infection, whether the infection is ongoing, recently cleared, or resolved decades ago.
When your doctor orders hepatitis B blood work, they’ll typically request total anti-HBc as part of the screening panel. IgM anti-HBc gets added when there’s a reason to suspect a new infection.
How Results Are Interpreted
Anti-HBc alone doesn’t tell the full story. It’s always read alongside two other markers: hepatitis B surface antigen (HBsAg), which indicates active virus in the blood, and antibody to the surface antigen (anti-HBs), which indicates immunity. The combination of all three creates a pattern that reveals your infection status.
A negative total anti-HBc with negative HBsAg and negative anti-HBs means you’ve never been infected and aren’t immune. You’re a candidate for vaccination. If anti-HBc is negative but anti-HBs is positive, you’re immune from vaccination rather than natural infection.
When total anti-HBc is positive along with HBsAg and IgM anti-HBc, you’re likely in the acute phase of a new infection. If HBsAg is positive but IgM anti-HBc is negative, the pattern points to chronic hepatitis B. And if HBsAg is negative while both total anti-HBc and anti-HBs are positive, you’ve recovered from a past infection and have natural immunity.
The “Isolated Positive” Result
Sometimes a person tests positive for total anti-HBc but negative for everything else: no surface antigen, no surface antibody. This pattern, called isolated anti-HBc, can be confusing because it doesn’t fit neatly into one category. According to the CDC, there are four possible explanations.
The most common is a resolved infection where anti-HBs levels have gradually declined below the detectable threshold over the years. The person cleared the virus long ago, but the only remaining evidence is the anti-HBc that persists for life. A second possibility is occult hepatitis B, where the virus is present at very low levels in the liver or blood but surface antigen testing doesn’t pick it up. Third, the person could have a chronic infection caused by a mutant strain of the virus that produces a surface antigen standard tests don’t recognize. The fourth explanation is simply a false positive, though modern anti-HBc tests have a false-positive rate below 2 per 1,000, making this uncommon.
If you get an isolated positive result, your doctor will likely order additional testing, particularly HBV DNA (a direct measure of viral genetic material), to sort out which scenario applies.
Why Anti-HBc Matters for Reactivation Risk
Even after you’ve recovered from hepatitis B and feel perfectly healthy, small amounts of the virus can remain dormant in liver cells. For most people, the immune system keeps this in check indefinitely. But treatments that suppress the immune system, including certain cancer therapies, medications for autoimmune conditions, and drugs given after organ transplants, can allow the virus to reactivate.
A study of solid-organ transplant recipients found that anti-HBc-positive status was the single strongest predictor of hepatitis B reactivation. Among 55 anti-HBc-positive recipients who weren’t given preventive antiviral treatment, about 4% experienced reactivation within five years. The patients who reactivated had low or undetectable anti-HBs levels before transplant, suggesting that having a strong surface antibody provides some additional protection. All patients who reactivated developed high viral loads and tested positive again for HBsAg.
This is why the CDC recommends counseling anyone with a resolved infection (positive anti-HBc, positive anti-HBs, negative HBsAg) about reactivation risk before they start immunosuppressive therapy.
Anti-HBc and Blood Donation
The FDA requires that all donated blood be screened for anti-HBc. Units that test positive are not used for transfusion. If you test repeatedly reactive for anti-HBc on more than one occasion, you’re indefinitely deferred from donating whole blood and blood components. There’s no reentry protocol currently available because no confirmatory test exists to definitively rule out low-level infection. This policy exists to protect blood recipients from occult hepatitis B that might not show up on surface antigen testing alone.
Current Screening Recommendations
In 2023, the CDC updated its hepatitis B screening guidelines with a significant change: all adults aged 18 and older should be screened at least once during their lifetime using a three-test panel. That panel includes HBsAg, anti-HBs, and total anti-HBc. Previously, screening was recommended only for people in high-risk groups, which meant many infections went undetected.
The inclusion of total anti-HBc in universal screening reflects its unique role. It’s the only marker that catches every form of hepatitis B exposure, whether the infection is current, chronic, or resolved. Without it, a person with a past infection and waning anti-HBs could appear identical on paper to someone who was never infected or vaccinated, missing an opportunity to counsel them about reactivation risk or check for occult infection.